Greg Bell, Andrew Tepperman, and Justin Ho co-authored a chapter in the ninth edition of The Investment Treaty Arbitration Review. The chapter titled “Investment Treaty Disputes in the Life Sciences Industry” addresses the features and incentives of the life sciences industry as they lead to tensions and disputes between governments and companies. The chapter further discusses valuation considerations for practitioners and future issues arising from current developments in the life sciences industry.
Navigating JCA for Orphan Medicinal Products: From scope simulation to pragmatic evidence generation for optimal patient access
The EU’s JCA framework is intended to streamline clinical evaluations and create a more consistent foundation for health technology assessments (HTAs) across...